Literature DB >> 2499725

Bacillus cereus septicemia associated with rhabdomyolysis and myoglobinuric renal failure.

J Tomiyama1, Y Hasegawa, T Nagasawa, T Abe, H Horiguchi, T Ogata.   

Abstract

A patient with acute myeloblastic leukemia (AML) developed septicemia due to Bacillus cereus with subsequent rhabdomyolysis and myoglobinuric renal failure. He died despite intensive care. Postmortem examination revealed diffuse muscle necrosis with infiltration of Gram-positive bacilli and widespread bacterial microthrombi in various organs. Septicemia associated with rhabdomyolysis has been described in 12 cases. This case represents the first reported case of B. cereus septicemia associated rhabdomyolysis. Renal failure and shock were considered to be the most important prognostic factors, and either direct infiltration or toxin of the bacteria was suggested to be the mechanism of rhabdomyolysis in sepsis. B. cereus can be one of the lethal organisms in immunocompromised patient such as the present case. Rhabdomyolysis should be considered when a patient with septicemia complains of muscle pain. Prompt hydration and correction of acidosis are important to prevent renal failure and shock.

Entities:  

Mesh:

Year:  1989        PMID: 2499725     DOI: 10.2169/internalmedicine1962.28.247

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  3 in total

1.  Invasive Bacillus cereus infection in a renal transplant patient: A case report and review.

Authors:  Susan John; John Neary; Christine H Lee
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

2.  Skeletal muscle oedema and muscle fibre necrosis during septic shock. Observations with a porcine septic shock model.

Authors:  S Hauptmann; B Klosterhalfen; J Weis; C Mittermayer; C J Kirkpatrick
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Synthesis, characterization, and antimicrobial efficacy of composite films from guar gum/sago starch/whey protein isolate loaded with carvacrol, citral and carvacrol-citral mixture.

Authors:  Chanda Vilas Dhumal; Kunal Pal; Preetam Sarkar
Journal:  J Mater Sci Mater Med       Date:  2019-10-17       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.